---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-092011"
form_type: "8-K"
ticker: "ITRMF"
cik: "0001659323"
company_name: "Iterum Therapeutics plc"
filed_at: "2024-08-06T23:59:59+00:00"
generated_at: "2026-05-31T12:19:46.126866+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Iterum Therapeutics rights offering expires; expects $7.4M gross proceeds

## Summary
- Rights offering expired Aug 6, 2024; gross proceeds est. $7.4M, net ~$6.3M after $1.1M expenses.
- 17,007,601 rights distributed; each allowed purchase of 0.50 Units at $0.605.
- Basic subscription: 6,121,965 Units; over-subscription of 5,091,550 Units fully honored.
- Each Unit includes 1 share, 0.50 1-yr warrant ($1.21 strike), and 1 5-yr warrant ($1.21).
- Shares and warrants expected to be delivered on or about Aug 9, 2024.

## SEC filing metadata
- accession: 0000950170-24-092011
- form_type: 8-K
- ticker: ITRMF
- cik: 0001659323
- company_name: Iterum Therapeutics plc
- filed_at: 2024-08-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1659323/000095017024092011/0000950170-24-092011-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1659323/000095017024092011/itrm-20240806.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-092011
- JSON: https://secwatch.observer/filing/0000950170-24-092011.json
- Plain text: https://secwatch.observer/filing/0000950170-24-092011.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.